These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30833082)

  • 1. The interaction between Vav1 and EBNA1 promotes survival of Burkitt's lymphoma cells by down-regulating the expression of Bim.
    Wang R; Wang J; Zhang N; Wan Y; Liu Y; Zhang L; Pan S; Zhang C; Zhang H; Cao Y
    Biochem Biophys Res Commun; 2019 Apr; 511(4):787-793. PubMed ID: 30833082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1.
    Watanabe A; Maruo S; Ito T; Ito M; Katsumura KR; Takada K
    J Virol; 2010 Mar; 84(6):2893-901. PubMed ID: 20042495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells.
    Hong M; Murai Y; Kutsuna T; Takahashi H; Nomoto K; Cheng CM; Ishizawa S; Zhao QL; Ogawa R; Harmon BV; Tsuneyama K; Takano Y
    J Cancer Res Clin Oncol; 2006 Jan; 132(1):1-8. PubMed ID: 16180023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma.
    Anderton E; Yee J; Smith P; Crook T; White RE; Allday MJ
    Oncogene; 2008 Jan; 27(4):421-33. PubMed ID: 17653091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice.
    Bristol JA; Nelson SE; Ohashi M; Casco A; Hayes M; Ranheim EA; Pawelski AS; Singh DR; Hodson DJ; Johannsen EC; Kenney SC
    PLoS Pathog; 2024 Apr; 20(4):e1012132. PubMed ID: 38620028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-barr virus-induced resistance to drugs that activate the mitotic spindle assembly checkpoint in Burkitt's lymphoma cells.
    Leao M; Anderton E; Wade M; Meekings K; Allday MJ
    J Virol; 2007 Jan; 81(1):248-60. PubMed ID: 17035311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic features and Epstein-Barr virus infection status of Burkitt's lymphoma in Guangzhou district.
    Huang YH; Wu QL; Zong YS; Feng YF; Liang JZ; Hou JH; Shao Q; Fu J
    Ai Zheng; 2009 Aug; 28(8):805-12. PubMed ID: 19664325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.
    Hochberg D; Middeldorp JM; Catalina M; Sullivan JL; Luzuriaga K; Thorley-Lawson DA
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):239-44. PubMed ID: 14688409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
    De Leo A; Arena G; Stecca C; Raciti M; Mattia E
    Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers.
    Bornkamm GW
    Int J Cancer; 2009 Apr; 124(8):1745-55. PubMed ID: 19165855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different patterns of Epstein-Barr virus latency in endemic Burkitt lymphoma (BL) lead to distinct variants within the BL-associated gene expression signature.
    Kelly GL; Stylianou J; Rasaiyaah J; Wei W; Thomas W; Croom-Carter D; Kohler C; Spang R; Woodman C; Kellam P; Rickinson AB; Bell AI
    J Virol; 2013 Mar; 87(5):2882-94. PubMed ID: 23269792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells.
    Flavell JR; Baumforth KR; Wood VH; Davies GL; Wei W; Reynolds GM; Morgan S; Boyce A; Kelly GL; Young LS; Murray PG
    Blood; 2008 Jan; 111(1):292-301. PubMed ID: 17720884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
    J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers.
    Daskalogianni C; Pyndiah S; Apcher S; Mazars A; Manoury B; Ammari N; Nylander K; Voisset C; Blondel M; FĂ„hraeus R
    J Pathol; 2015 Jan; 235(2):334-41. PubMed ID: 25186125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas.
    Habeshaw G; Yao QY; Bell AI; Morton D; Rickinson AB
    J Virol; 1999 Feb; 73(2):965-75. PubMed ID: 9882297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus.
    Westhoff Smith D; Sugden B
    Viruses; 2013 Jan; 5(1):226-40. PubMed ID: 23325328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
    Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines.
    Perez-Chacon G; de Los Rios C; Zapata JM
    Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2.
    AlQarni S; Al-Sheikh Y; Campbell D; Drotar M; Hannigan A; Boyle S; Herzyk P; Kossenkov A; Armfield K; Jamieson L; Bailo M; Lieberman PM; Tsimbouri P; Wilson JB
    Oncogene; 2018 Jul; 37(29):3998-4012. PubMed ID: 29691476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EBNA1.
    Frappier L
    Curr Top Microbiol Immunol; 2015; 391():3-34. PubMed ID: 26428370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.